California Nanotechnologies Corp. (CNO) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Earth Alive Clean Technologies, Inc.

Rapid Dose Therapeutics Corp.

Avicanna, Inc.

California Nanotechnologies Corp.

Microbix Biosystems, Inc.

Ceapro, Inc.

Cardiol Therapeutics, Inc.

FSD Pharma, Inc.

Medicenna Therapeutics Corp.

Hemostemix, Inc.

Cognetivity Neurosciences Ltd.

Why is California Nanotechnologies Corp. ?

With a fall in PBT of -140128.29%, the company declared Very Negative results in May 25

The company has declared negative results in Nov 24 after 5 consecutive negative quarters
NET PROFIT(Q) At CAD -0.63 MM has Fallen at -2,109.31%
ROCE(HY) Lowest at -86.1%
PRE-TAX PROFIT(Q) Lowest at CAD -0.63 MM

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -70.34%, its profits have fallen by -250%

Underperformed the market in the last 1 year

Even though the market (S&P/TSX 60) has generated returns of 18.73% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -70.34% returns

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is California Nanotechnologies Corp. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

California Nanotechnologies Corp.

-70.59%

11.11

103.58%

S&P/TSX 60

19.1%

1.23

15.27%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

40.07%

EBIT Growth (5y)

-24.83%

EBIT to Interest (avg)

0.62

Debt to EBITDA (avg)

1.05

Net Debt to Equity (avg)

-0.09

Sales to Capital Employed (avg)

2.39

Tax Ratio

24.17%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

39.85%

ROE (avg)

25.88%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

5.78

EV to EBIT

-18.91

EV to EBITDA

18.91

EV to Capital Employed

5.66

EV to Sales

3.05

PEG Ratio

Dividend Yield

ROCE (Latest)

-24.50%

ROE (Latest)

-68.24%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

Bearish

Bullish

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Mildly Bearish

Dow Theory

Mildly Bearish

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CAD 4.54 MM

-27What is not working for the Company

NET PROFIT(Q)

At CAD -0.63 MM has Fallen at -2,109.31%

ROCE(HY)

Lowest at -86.1%

PRE-TAX PROFIT(Q)

Lowest at CAD -0.63 MM

RAW MATERIAL COST(Y)

Grown by 121.46% (YoY

NET SALES(Q)

Lowest at CAD 1.01 MM

OPERATING PROFIT(Q)

Lowest at CAD -0.35 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -34.8 %

Here's what is working for California Nanotechnologies Corp.

Operating Cash Flow

Highest at CAD 4.54 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CAD MM)

Here's what is not working for California Nanotechnologies Corp.

Net Sales

At CAD 1.01 MM has Fallen at -53.1%

over average net sales of the previous four periods of CAD 2.15 MM

MOJO Watch

Near term sales trend is extremely negative

Net Sales (CAD MM)

Pre-Tax Profit

At CAD -0.63 MM has Fallen at -787.68%

over average net sales of the previous four periods of CAD 0.09 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CAD MM)

Net Profit

At CAD -0.63 MM has Fallen at -2,109.31%

over average net sales of the previous four periods of CAD 0.03 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CAD MM)

Pre-Tax Profit

Lowest at CAD -0.63 MM and Fallen

In each period in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CAD MM)

Net Sales

Lowest at CAD 1.01 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CAD MM)

Operating Profit

Lowest at CAD -0.35 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CAD MM)

Operating Profit Margin

Lowest at -34.8 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Raw Material Cost

Grown by 121.46% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales